BridgeMD
New treatment option for Aortic Stenosis Disease
Official title Impact of Enhanced Information on Subjective Information Level and PROMs in Patients with Aortic Stenosis
ClinicalTrials.gov ID: NCT06706635
What this study is testing
- What it's testing
- The aim of this trial is to evaluate if an enhanced information by using a mobile App can increase subjective information level in patients with severe aortic stenosis and may therefore improve patient-reported outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- severe aortic valve stenosis
- planned aortic valve replacement (TAVI)
- Patient is willing and able to complete the surveys in German language
- Written informed consent by the trial subject
You likely can't join if
- \- Language barrier
The study team makes the final eligibility decision.
Where it's taking place
- Bad Oeynhausen, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bad Oeynhausen, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.